Literature DB >> 19023118

Impaired negative regulation of homeostatically proliferating T cells.

Anna Shvets1, Rabindranath Chakrabarti, Rosana Gonzalez-Quintial, Roberto Baccala, Argyrios N Theofilopoulos, Gérald J Prud'homme.   

Abstract

Acute lymphopenia-induced homeostatic proliferation (HP) of T cells promotes antitumor immunity, but the mechanism is unclear. We hypothesized that this is due to a lack of inhibitory signals that allows activation of T cells with low affinity for self-antigens. Tumors resist immunity in part by expressing inhibitory molecules such as PD-1 ligand 1 (PD-L1), B7-H4, and TGF-beta. In irradiated mice undergoing HP, we found that T cells displayed a severe deficit in the activation-induced expression of inhibitory molecules PD-1 and CTLA-4, and TGF-beta1-induced expression of Foxp3. HP T cells were also less suppressed by B7-H4/Ig and, unlike control T cells, failed to produce IL-10 in response to this molecule. This deficiency in regulation was reversed as normal T-cell numbers were restored. We conclude that T cells are weakly regulated by inhibitory molecules during the acute phase of HP, which could explain their increased effectiveness in cancer immunotherapy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19023118      PMCID: PMC2948436          DOI: 10.1182/blood-2008-03-139964

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  25 in total

1.  Development of antitumor immune responses in reconstituted lymphopenic hosts.

Authors:  Hong-Ming Hu; Christian H Poehlein; Walter J Urba; Bernard A Fox
Journal:  Cancer Res       Date:  2002-07-15       Impact factor: 12.701

Review 2.  Checkpoint blockade in cancer immunotherapy.

Authors:  Alan J Korman; Karl S Peggs; James P Allison
Journal:  Adv Immunol       Date:  2006       Impact factor: 3.543

Review 3.  Interaction of PD-L1 on tumor cells with PD-1 on tumor-specific T cells as a mechanism of immune evasion: implications for tumor immunotherapy.

Authors:  Christian Blank; Thomas F Gajewski; Andreas Mackensen
Journal:  Cancer Immunol Immunother       Date:  2004-12-15       Impact factor: 6.968

4.  Prevention of autoimmune diabetes by intramuscular gene therapy with a nonviral vector encoding an interferon-gamma receptor/IgG1 fusion protein.

Authors:  G J Prud'homme; Y Chang
Journal:  Gene Ther       Date:  1999-05       Impact factor: 5.250

Review 5.  Tumor immunity via homeostatic T cell proliferation: mechanistic aspects and clinical perspectives.

Authors:  Roberto Baccala; Rosana Gonzalez-Quintial; Wolfgang Dummer; Argyrios N Theofilopoulos
Journal:  Springer Semin Immunopathol       Date:  2005-01-22

6.  The generation of protective memory-like CD8+ T cells during homeostatic proliferation requires CD4+ T cells.

Authors:  Sara E Hamilton; Monika C Wolkers; Stephen P Schoenberger; Stephen C Jameson
Journal:  Nat Immunol       Date:  2006-04-09       Impact factor: 25.606

7.  A mutant B7-1/Ig fusion protein that selectively binds to CTLA-4 ameliorates anti-tumor DNA vaccination and counters regulatory T cell activity.

Authors:  Rabindranath Chakrabarti; Zheng F Zhou; Yigang Chang; Gérald J Prud'homme
Journal:  Vaccine       Date:  2005-08-31       Impact factor: 3.641

8.  T cell homeostatic proliferation elicits effective antitumor autoimmunity.

Authors:  Wolfgang Dummer; Andreas G Niethammer; Roberto Baccala; Brian R Lawson; Norbert Wagner; Ralph A Reisfeld; Argyrios N Theofilopoulos
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

9.  Accelerated memory cell homeostasis during T cell depletion and approaches to overcome it.

Authors:  David C Neujahr; Chuangqi Chen; Xiaolun Huang; James F Markmann; Stephen Cobbold; Herman Waldmann; Mohamed H Sayegh; Wayne W Hancock; Laurence A Turka
Journal:  J Immunol       Date:  2006-04-15       Impact factor: 5.422

10.  CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation.

Authors:  M F Krummel; J P Allison
Journal:  J Exp Med       Date:  1995-08-01       Impact factor: 14.307

View more
  10 in total

1.  Stable activity of diabetogenic cells with age in NOD mice: dynamics of reconstitution and adoptive diabetes transfer in immunocompromised mice.

Authors:  Ayelet Kaminitz; Keren Mizrahi; Shifra Ash; Avi Ben-Nun; Nadir Askenasy
Journal:  Immunology       Date:  2014-07       Impact factor: 7.397

2.  CD18 is required for optimal lymphopenia-induced proliferation of mouse T cells.

Authors:  Ritu Sarin; Clara Abraham
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-07-19       Impact factor: 4.052

3.  Blockade of programmed death ligand 1 enhances the therapeutic efficacy of combination immunotherapy against melanoma.

Authors:  Shari Pilon-Thomas; Amy Mackay; Nasreen Vohra; James J Mulé
Journal:  J Immunol       Date:  2010-03-01       Impact factor: 5.422

4.  Quantitative monitoring of mouse lung tumors by magnetic resonance imaging.

Authors:  Alexander Sasha Krupnick; Vanessa K Tidwell; John A Engelbach; Vamsi V Alli; Arye Nehorai; Ming You; Haris G Vikis; Andrew E Gelman; Daniel Kreisel; Joel R Garbow
Journal:  Nat Protoc       Date:  2012-01-05       Impact factor: 13.491

5.  Arthritogenic T cells drive the recovery of autoantibody-producing B cell homeostasis and the adoptive transfer of arthritis in SCID mice.

Authors:  Katalin Kis-Toth; Marianna Radacs; Katalin Olasz; Willem van Eden; Katalin Mikecz; Tibor T Glant
Journal:  Int Immunol       Date:  2012-04-19       Impact factor: 4.823

Review 6.  Mechanisms of autoimmunity in the non-obese diabetic mouse: effector/regulatory cell equilibrium during peak inflammation.

Authors:  Nadir Askenasy
Journal:  Immunology       Date:  2016-02-08       Impact factor: 7.397

Review 7.  Mechanisms of diabetic autoimmunity: I--the inductive interface between islets and the immune system at onset of inflammation.

Authors:  Nadir Askenasy
Journal:  Immunol Res       Date:  2016-04       Impact factor: 2.829

8.  Adaptive and innate transforming growth factor beta signaling impact herpes simplex virus 1 latency and reactivation.

Authors:  Sariah J Allen; Kevin R Mott; Steven L Wechsler; Richard A Flavell; Terrence Town; Homayon Ghiasi
Journal:  J Virol       Date:  2011-08-31       Impact factor: 5.103

Review 9.  The inhibitory role of b7-h4 in antitumor immunity: association with cancer progression and survival.

Authors:  Changjun He; Haiquan Qiao; Hongchi Jiang; Xueying Sun
Journal:  Clin Dev Immunol       Date:  2011-10-13

10.  Unique human immune signature of Ebola virus disease in Guinea.

Authors:  Paula Ruibal; Lisa Oestereich; Anja Lüdtke; Beate Becker-Ziaja; David M Wozniak; Romy Kerber; Miša Korva; Mar Cabeza-Cabrerizo; Joseph A Bore; Fara Raymond Koundouno; Sophie Duraffour; Romy Weller; Anja Thorenz; Eleonora Cimini; Domenico Viola; Chiara Agrati; Johanna Repits; Babak Afrough; Lauren A Cowley; Didier Ngabo; Julia Hinzmann; Marc Mertens; Inês Vitoriano; Christopher H Logue; Jan Peter Boettcher; Elisa Pallasch; Andreas Sachse; Amadou Bah; Katja Nitzsche; Eeva Kuisma; Janine Michel; Tobias Holm; Elsa-Gayle Zekeng; Isabel García-Dorival; Roman Wölfel; Kilian Stoecker; Erna Fleischmann; Thomas Strecker; Antonino Di Caro; Tatjana Avšič-Županc; Andreas Kurth; Silvia Meschi; Stephane Mély; Edmund Newman; Anne Bocquin; Zoltan Kis; Anne Kelterbaum; Peter Molkenthin; Fabrizio Carletti; Jasmine Portmann; Svenja Wolff; Concetta Castilletti; Gordian Schudt; Alexandra Fizet; Lisa J Ottowell; Eva Herker; Thomas Jacobs; Birte Kretschmer; Ettore Severi; Nobila Ouedraogo; Mar Lago; Anabel Negredo; Leticia Franco; Pedro Anda; Stefan Schmiedel; Benno Kreuels; Dominic Wichmann; Marylyn M Addo; Ansgar W Lohse; Hilde De Clerck; Carolina Nanclares; Sylvie Jonckheere; Michel Van Herp; Armand Sprecher; Gao Xiaojiang; Mary Carrington; Osvaldo Miranda; Carlos M Castro; Martin Gabriel; Patrick Drury; Pierre Formenty; Boubacar Diallo; Lamine Koivogui; N'Faly Magassouba; Miles W Carroll; Stephan Günther; César Muñoz-Fontela
Journal:  Nature       Date:  2016-05-05       Impact factor: 49.962

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.